SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-023740
Filing Date
2024-07-29
Accepted
2024-07-29 16:25:15
Documents
23
Period of Report
2024-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240727_8k.htm   iXBRL 8-K 46104
2 EXHIBIT 1.1 ex_704469.htm EX-1.1 244692
3 EXHIBIT 4.1 ex_704465.htm EX-4.1 128738
4 EXHIBIT 4.2 ex_704466.htm EX-4.2 123595
5 EXHIBIT 4.3 ex_704467.htm EX-4.3 119709
6 EXHIBIT 4.4 ex_704468.htm EX-4.4 117978
7 EXHIBIT 10.1 ex_704464.htm EX-10.1 133923
8 EXHIBIT 99.1 ex_704459.htm EX-99.1 13891
9 EXHIBIT 99.2 ex_704831.htm EX-99.2 12982
14 logo.jpg GRAPHIC 3886
  Complete submission text file 0001437749-24-023740.txt   1287568

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA nby-20240726.xsd EX-101.SCH 3401
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240726_def.xml EX-101.DEF 11421
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240726_lab.xml EX-101.LAB 15310
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240726_pre.xml EX-101.PRE 11581
25 EXTRACTED XBRL INSTANCE DOCUMENT nby20240727_8k_htm.xml XML 2850
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 241152705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)